Early research (Phase 1)Study completedNCT02686372
What this trial is testing
TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation
Who this might be right for
Hepatocellular Carcinoma
Lion TCR Pte. Ltd. 13